These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The hamster (Mesocricetus auratus) as experimental model in Chagas' disease: parasitological and histopathological studies in acute and chronic phases of Trypanosoma cruzi infection. Ramírez LE; Lages-Silva E; Soares Júnior JM; Chapadeiro E Rev Soc Bras Med Trop; 1994; 27(3):163-9. PubMed ID: 7972946 [TBL] [Abstract][Full Text] [Related]
27. [Comparison of histologic changes in Chagas' cardiomyopathy and dilated cardiomyopathy]. Barretto AC; Higuchi ML; da Luz PL; Lopes EA; Bellotti G; Mady C; Stolf N; Arteaga-Fernández E; Pileggi F Arq Bras Cardiol; 1989 Feb; 52(2):79-83. PubMed ID: 2596992 [TBL] [Abstract][Full Text] [Related]
28. TNF gene polymorphisms are associated with reduced survival in severe Chagas' disease cardiomyopathy patients. Drigo SA; Cunha-Neto E; Ianni B; Cardoso MR; Braga PE; Faé KC; Nunes VL; Buck P; Mady C; Kalil J; Goldberg AC Microbes Infect; 2006 Mar; 8(3):598-603. PubMed ID: 16427798 [TBL] [Abstract][Full Text] [Related]
29. Pentoxifylline reduces inflammation and prevents myocardial perfusion derangements in experimental chronic Chagas' cardiomyopathy. Tanaka DM; Fabricio CG; Marin-Neto JA; de Barros Filho ACL; de Oliveira LFL; Mejia J; Almeida RR; de Souza Vieira R; Lopes CD; Batah SS; Moreira HT; de Lourdes Higuchi M; Neto EC; Fabro AT; Nekolla SG; Romano MMD; Simões MV J Nucl Cardiol; 2023 Dec; 30(6):2327-2337. PubMed ID: 37165114 [TBL] [Abstract][Full Text] [Related]
30. Indeterminate Chagas' disease: Trypanosoma cruzi strain and re-infection are factors involved in the progression of cardiopathy. Bustamante JM; Rivarola HW; Fernández AR; Enders JE; Fretes R; Palma JA; Paglini-Oliva PA Clin Sci (Lond); 2003 Apr; 104(4):415-20. PubMed ID: 12653687 [TBL] [Abstract][Full Text] [Related]
32. Parasite persistence correlates with disease severity and localization in chronic Chagas' disease. Zhang L; Tarleton RL J Infect Dis; 1999 Aug; 180(2):480-6. PubMed ID: 10395865 [TBL] [Abstract][Full Text] [Related]
33. Heart-infiltrating and peripheral T cells in the pathogenesis of human Chagas' disease cardiomyopathy. Cunha-Neto E; Kalil J Autoimmunity; 2001; 34(3):187-92. PubMed ID: 11908776 [TBL] [Abstract][Full Text] [Related]
34. Pathology and Pathogenesis of Chagas Heart Disease. Bonney KM; Luthringer DJ; Kim SA; Garg NJ; Engman DM Annu Rev Pathol; 2019 Jan; 14():421-447. PubMed ID: 30355152 [TBL] [Abstract][Full Text] [Related]
35. Phosphoramidon treatment improves the consequences of chagasic heart disease in mice. Jelicks LA; Chandra M; Shtutin V; Petkova SB; Tang B; Christ GJ; Factor SM; Wittner M; Huang H; Douglas SA; Weiss LM; Orleans-Juste PD; Shirani J; Tanowitz HB Clin Sci (Lond); 2002 Aug; 103 Suppl 48():267S-271S. PubMed ID: 12193101 [TBL] [Abstract][Full Text] [Related]
36. Severity of chronic experimental Chagas' heart disease parallels tumour necrosis factor and nitric oxide levels in the serum: models of mild and severe disease. Pereira IR; Vilar-Pereira G; Silva AA; Lannes-Vieira J Mem Inst Oswaldo Cruz; 2014 Jun; 109(3):289-98. PubMed ID: 24937048 [TBL] [Abstract][Full Text] [Related]
37. Myocardial gene and protein expression profiles after autoimmune injury in Chagas' disease cardiomyopathy. Cunha-Neto E; Teixeira PC; Fonseca SG; Bilate AM; Kalil J Autoimmun Rev; 2011 Jan; 10(3):163-5. PubMed ID: 20883825 [TBL] [Abstract][Full Text] [Related]